Previous Article | Next Article ![]()
Infection and Immunity, March 2004, p. 1519-1529, Vol. 72, No. 3
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.3.1519-1529.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Institute of Medical Biochemistry, Göteborg University, SE 405 30 Göteborg,1 Department of Odontology/Oral Microbiology, Umeå University, SE 901 87 Umeå, Sweden2
Received 14 July 2003/ Returned for modification 22 October 2003/ Accepted 26 November 2003
Recognition of sialic acid-containing glycoconjugates by the human gastric pathogen Helicobacter pylori has been repeatedly demonstrated. To investigate the structural requirements for H. pylori binding to complex gangliosides, a large number of gangliosides were isolated and characterized by mass spectrometry and proton nuclear magnetic resonance. Ganglioside binding of sialic acid-recognizing H. pylori strains (strains J99 and CCUG 17874) and knockout mutant strains with the sialic acid binding adhesin SabA or the NeuAc
3Galß4GlcNAcß3Galß4GlcNAcß-binding neutrophil-activating protein HPNAP deleted was investigated using the thin-layer chromatogram binding assay. The wild-type bacteria bound to N-acetyllactosamine-based gangliosides with terminal
3-linked NeuAc, while gangliosides with terminal NeuGc
3, NeuAc
6, or NeuAc
8NeuAc
3 were not recognized. The factors affecting binding affinity were identified as (i) the length of the N-acetyllactosamine carbohydrate chain, (ii) the branches of the carbohydrate chain, and (iii) fucose substitution of the N-acetyllactosamine core chain. While the J99/NAP- mutant strain displayed a ganglioside binding pattern identical to that of the parent J99 wild-type strain, no ganglioside binding was obtained with the J99/SabA- mutant strain, demonstrating that the SabA adhesin is the sole factor responsible for the binding of H. pylori bacterial cells to gangliosides.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|